Posted on June 8, 20266/8/26
What’s Trending in Oncology? A Discussion Following ASCO 2026 with Anne Marie Robertson
Posted on June 3, 20266/3/26
You Cannot Commercialize What is Not Compliant
Posted on May 13, 20265/13/26
Views from Asembia: What Pharma Leaders Are Prioritizing Now
Posted on May 7, 20265/7/26
How Pharma Can Scale Innovation Without Losing Executional Rigor
Posted on April 13, 20264/13/26
Build the Launch, Then Cut the Deal: A Smarter Playbook for Emerging Biotech Value
Posted on March 25, 20263/25/26
Solving The Rare Disease Launch Paradox — Using Pre‑Launch Planning and Partnership to Create Value
Posted on February 10, 20262/10/26
Rewiring Commercialization for Biotech’s New Reality
Posted on January 30, 20261/30/26
Bringing a Breakthrough Rare Disease Therapy to Market with Rapid Speed for Patients
Posted on January 27, 20261/27/26
Insights from Frontiers Health 2025: The Future of Commercialization Models
Posted on January 20, 20261/20/26